(Q42808742)

7 November 2017

Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis (English)

1 reference

7 November 2017

1 reference

1 reference

1 reference

Maeda T

1

1 reference

7 November 2017

Desouky J

series ordinal

2

1 reference

7 November 2017

Friedl A

series ordinal

3

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

7 November 2017

1 reference

7 November 2017

25

1 reference

7 November 2017

1408-1412

1 reference

7 November 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209168

7 November 2017

0 references

cites work

High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Syndecan-1-mediated cell spreading requires signaling by αvβ3 integrins in human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Functions of cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Syndecan-1 ectodomain regulates matrix-dependent signaling in human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Syndecan-1 expression in thyroid carcinoma: stromal expression followed by epithelial expression is significantly correlated with dedifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Heparan sulfate proteoglycans from mouse mammary epithelial cells: localization on the cell surface with a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Order and disorder: the role of extracellular matrix in epithelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Fibroblast growth factor-2 can mediate cell attachment by linking receptors and heparan sulfate proteoglycans on neighboring cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Watch thy neighbor: cancer is a communal affair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Soluble syndecan-1 promotes growth of myeloma tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

7 January 2021

Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

7 January 2021

Transient expression of a cell surface heparan sulfate proteoglycan (syndecan) during limb development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

7 January 2021

Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

7 January 2021

Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

7 January 2021

Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209168

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209168

1 reference

Dimensions Publication ID

7 November 2017

0 references

1 reference